Rep. Daniel S. Goldman bought Johnson & Johnson (JNJ)
Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Feb 3, 2023
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Feb 3, 2023
- Disclosed
- Mar 20, 2023
- Days to disclose
- 45
- Asset type
- Stock
- As filed
- Johnson & Johnson
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
All of Goldman's trades →- Mar 20, 2023$1K–$15K
Sold (partial) West Japan Railway Company WJRYY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
Bought Vodafone Group Public Limited Company VOD
$15K–$50K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Sold UNIVERSAL MUSIC GROUP NV ADR CMN (UNVGY)
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
$15K–$50K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Sold (partial) Toyota Motor TM
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
Bought Tokyo Electron Limited TOELY
$15K–$50K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Sold (partial) Tokio Marine Holdings TKOMY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$15K–$50K
$15K–$50K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Bought Techtronic Industries Company Limited TTNDY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Bought Takeda Pharmaceutical Company Limited TAK
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$50K–$100K
Sold (partial) Taiwan Semiconductor Manufacturing Company Limited TSM
$50K–$100K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Bought Suntory Beverage & Food Limited STBFY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Sold (partial) Sumitomo Chemical Company, Limited SOMMY
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 20, 2023$1K–$15K
Bought SOMPO JAPAN NIPPONKOA HLDGS IN ADR CMN (SMPNY)
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
Recent Congress trades in JNJ
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and CommerceTraded 13 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 5, 2026$1K–$15K
Rep. Lloyd Doggett (D-TX-37)
$1K–$15K · Traded Sep 8, 2026 · disclosed Oct 5, 2026
- Sep 12, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Aug 27, 2026 · disclosed Sep 12, 2026
Committee overlap: Energy and Commerce - Sep 11, 2026$1K–$15K
Sen. John Boozman (R-AR)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 11, 2026 · Joint
- Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 30, 2026 · disclosed Jul 21, 2026 · filed 113 days later
Committee overlap: HELP
Company context for JNJ
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
JNJ: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.
2 congressional households disclosed purchases in the past 90 days. See the trades
JNJ: third_quarter 2026 lobbying report
Issues related to the 340B Drug Pricing Program. Issues related to the 340B Drug Pricing Program.
Public: Oct 20, 2026, 12:00 AM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
JNJ: third_quarter 2026 lobbying report
HR 6549, VA Contracting and Procurement Act PBM Medical Supply Chain program reforms, MSPV, PSAS, IT HR 9237, Taking Care of Veterans Act S2918, Veterans Prosthetics Advancement and Reform Act
Public: Oct 16, 2026, 12:14 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.